Sabatier et al. [22] investigated the PDL1 level in 5, 454 breast cancers using DNA microarray and demonstrated that higher PDL1 expression was associated with better metastasis-free survival and OSS and better response to chemotherapy. The gene discussed is CD274; the disease is breast carcinoma.